Tag: TNK
Tenecteplase-related clot migration does not create a “clinical penalty” for stroke...
At this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (2–4 September, Marseille, France), NeuroNews spoke with Jildaz Caroff (Bicêtre Hospital, Paris,...
TNKase gains US FDA approval for acute ischaemic stroke treatment
Genentech, a member of the Roche Group, has announced the US Food and Drug Administration (FDA) approval of the thrombolytic agent TNKase (tenecteplase) for the...
Varied tenecteplase data may provide clarity on the drug’s exact role...
This year’s European Stroke Organisation Conference (ESOC; 15–17 May, Basel, Switzerland) saw a plethora of data on intravenous tenecteplase—from studies spanning Australia, Canada, China,...
Tenecteplase linked to higher haemorrhage rates than alteplase in no-thrombectomy stroke...
Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from...
